Regulatory Filings • Mar 21, 2008
Regulatory Filings
Open in ViewerOpens in native device viewer
_________ false
C001��� �� �� ������������� ��"�2PublicX T L BIOPHARMACEUTICALS LTD4313Corporation no: 520039470Stock Exchange/Market: ��� �� ��1996379Hasapir 3 , Nes Ziona 76100 , ,Tel: 08-9304444 , Fax: 08-9304445E.mail address: [email protected] of transmission: 20/03/2008 Time of broadcast: 23:54 23:53:43
Reference: 2008-02-079575
| Israel Securities Authority | Tel Aviv Stock Exchange | |||||
| www.isa.gov.il | www.tase.co.il |
Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
| Attached hereto is a report on |
| Financial Results for the Year Ended December 31, 2007 |
| 2007XTLEarningsReleaseFinal_isa.pdf |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): |
| Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD |
| Date of revision of form structure: 14/02/2008 |
| - - - |
| Name of the Signatory: : Kantor Ronen , Name of Employer Company: , Position of Signatory in the reporting corporation: Legal Consultant & Corporate Secretary |
| Abba Hillel Silver Telephone: 03-6133371 , Facsimile: 03-6133372 , E-mail: [email protected] 2 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.